The Enzymology of CAAX Protein Prenylation

Enzymes

Volumn 30, Issue , 2011, Pages 1-11

  Hightower, Kendra E ^a,b   Casey, Patrick J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

CAAX protein; Farnesyl; Geranylgeranyl; Isoprenylation; Prenylation; Transferase

Indexed keywords

EID: 81255189465     PISSN: 18746047     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-415922-8.00001-X     Document Type: Chapter

References (65)

1. Zhang F.L., Casey P.J. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 1996, 65:241-269.
2. Gelb M.H., Brunsveld L., Hrycyna C.A., Michaelis S., Tamanoi F., Van Voorhis W.C., Waldmann H. Therapeutic intervention based on protein prenylation and associated modifications. Nat Chem Biol 2006, 2:518-528.
3. Reiss Y., Goldstein J.L., Seabra M.C., Casey P.J., Brown M.S. Inhibition of purified p21ras farnesyl:protein transferase by cys-aax tetrapeptides. Cell 1990, 62:81-88.
4. Casey P.J., Thissen J.A., Moomaw J.F. Enzymatic modification of proteins with a geranylgeranyl isoprenoid. Proc Natl Acad Sci USA 1991, 88:8631-8635.
5. Yokoyama K., Goodwin G.W., Ghomashchi F., Glomset J.A., Gelb M.H. A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity. Proc Natl Acad Sci USA 1991, 88:5302-5306.
6. Gibbs J.B., Oliff A., Kohl N.E. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 1994, 77:175-178.
7. Malumbres M., Barbacid M. Ras oncogenes: the first 30 years. Nat Rev Cancer 2003, 3:459-465.
8. Karp J.E., Lancet J.E. Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies. Cancer Invest 2007, 25:484-494.
9. Sousa S., Fernandes P., Ramos M. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem. Curr Med Chem 2008, 15:1478-1492.
10. O'Dwyer P.J., Gallagher M., Nguyen B., Waddell M.J., Chiorean E.J. Phase accelerated dose-escalating safety and pharmacokinetic study of GGTI-2419, a novel geranylgeranyltransferase I inhibitor, in patients with refractory solid tumors. Ann Oncol 2010, 21(Suppl. 2):ii42.
11. Moomaw J.F., Casey P.J. Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements. J Biol Chem 1992, 267:17438-17443.
12. Andres D.A., Milatovich A., Ozcelik T., Wenzlau J.M., Brown M.S., Goldstein J.L., Francke U. Cdna cloning of the two subunits of human CAAX farnesyltransferase and chromosomal mapping of FTNA and FTNB loci and related sequences. Genomics 1993, 18:105-112.
13. Omer C.A., Kral A.M., Diehl R.E., Prendergast G.C., Powers S., Allen C.M., Gibbs J.B., Kohl N.E. Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases. Biochemistry 1993, 32:5167-5176.
14. Park H.W., Boduluri S.R., Moomaw J.F., Casey P.J., Beese L.S. Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution. Science 1997, 275:1800-1804.
15. Chen W.J., Moomaw J.F., Overton L., Kost T.A., Casey P.J. High level expression of mammalian protein farnesyltransferase in a baculovirus system. The purified protein contains zinc. J Biol Chem 1993, 268:9675-9680.
16. Reiss Y., Brown M.S., Goldstein J.L. Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme. J Biol Chem 1992, 267:6403-6408.
17. Long S.B., Casey P.J., Beese L.S. Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate. Biochemistry 1998, 37:9612-9618.
18. Long S.B., Casey P.J., Beese L.S. Reaction path of protein farnesyltransferase at atomic resolution. Nature 2002, 419:645-650.
19. Taylor J.S., Reid T.S., Terry K.L., Casey P.J., Beese L.S. Structure of mammalian protein geranylgeranyltransferase type-I. EMBO J 2003, 22:5963-5974.
20. Reid T.S., Terry K.L., Casey P.J., Beese L.S. Crystallographic analysis of caax prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J Mol Biol 2004, 343:417-433.
21. Strickland C.L., Windsor W.T., Syto R., Wang L., Bond R., Wu Z., Schwartz J., Le H.V., Beese L.S., Weber P.C. Crystal structure of farnesyl protein transferase complexed with a CAAX peptide and farnesyl diphosphate analogue. Biochemistry 1998, 37:16601-16611.
22. Reiss Y., Seabra M.C., Armstrong S.A., Slaughter C.A., Goldstein J.L., Brown M.S. Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions. J Biol Chem 1991, 266:10672-10677.
23. Yokoyama K., Gelb M.H. Purification of a mammalian protein geranylgeranyltransferase. Formation and catalytic properties of an enzyme-geranylgeranyl pyrophosphate complex. J Biol Chem 1993, 268:4055-4060.
24. Yokoyama K., Zimmerman K., Scholten J., Gelb M.H. Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation. J Biol Chem 1997, 272:3944-3952.
25. Furfine E.S., Leban J.J., Landavazo A., Moomaw J.F., Casey P.J. Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release. Biochemistry 1995, 34:6857-6862.
26. Bowers K.E., Fierke C.A. Positively charged side chains in protein farnesyltransferase enhance catalysis by stabilizing the formation of the diphosphate leaving group. Biochemistry 2004, 43:5256-5265.
27. Casey P.J., Seabra M.C. Protein prenyltransferases. J Biol Chem 1996, 271:5289-5292.
28. Pompliano D.L., Rands E., Schaber M.D., Mosser S.D., Anthony N.J., Gibbs J.B. Steady-state kinetic mechanism of ras farnesyl:protein transferase. Biochemistry 1992, 31:3800-3807.
29. Hightower K.E., Huang C.C., Casey P.J., Fierke C.A. H-ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate. Biochemistry 1998, 37:15555-15562.
30. Long S.B., Casey P.J., Beese L.S. The basis for K-ras4b binding specificity to protein farnesyltransferase revealed by 2 å resolution ternary complex structures. Struct Fold Des 2000, 8:209-222.
31. Huang C., Hightower K.E., Fierke C.A. Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state. Biochemistry 2000, 39:2593-2602.
32. Yokoyama K., McGeady P., Gelb M.H. Mammalian protein geranylgeranyltransferase-I: substrate specificity, kinetic mechanism, metal requirements, and affinity labeling. Biochemistry 1995, 34:1344-1354.
33. Krzysiak A.J., Rawat D.S., Scott S.A., Pais J.E., Handley M., Harrison M.L., Fierke C.A., Gibbs R.A. Combinatorial modulation of protein prenylation. ACS Chem Biol 2007, 2:385-389.
34. Krzysiak A.J., Aditya A.V., Hougland J.L., Fierke C.A., Gibbs R.A. Synthesis and screening of a caal peptide library versus FTase reveals a surprising number of substrates. Bioorg Med Chem Lett 2010, 20:767-770.
35. Hougland J.L., Hicks K.A., Hartman H.L., Kelly R.A., Watt T.J., Fierke C.A. Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities. J Mol Biol 2010, 395:176-190.
36. Tschantz W.R., Furfine E.S., Casey P.J. Substrate binding is required for release of product from mammalian protein farnesyltransferase. J Biol Chem 1997, 272:9989-9993.
37. Spence R.A., Hightower K.E., Terry K.L., Beese L.S., Fierke C.A., Casey P.J. Conversion of Tyr361 beta to leu in mammalian protein farnesyltransferase impairs product release but not substrate recognition. Biochemistry 2000, 39:13651-13659.
38. Huang C.C., Casey P.J., Fierke C.A. Evidence for a catalytic role of zinc in protein farnesyltransferase. Spectroscopy of Co2+-farnesyltransferase indicates metal coordination of the substrate thiolate. J Biol Chem 1997, 272:20-23.
39. Rozema D.B., Poulter C.D. Yeast protein farnesyltransferase. pKas of peptide substrates bound as zinc thiolates. Biochemistry 1999, 38:13138-13146.
40. Saderholm M.J., Hightower K.E., Fierke C.A. Role of metals in the reaction catalyzed by protein farnesyltransferase. Biochemistry 2000, 39:12398-12405.
41. Dolence J.M., Poulter C.D. A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase. Proc Natl Acad Sci USA 1995, 92:5008-5011.
42. Clausen V.A., Edelstein R.L., Distefano M.D. Stereochemical analysis of the reaction catalyzed by human protein geranylgeranyl transferase. Biochemistry 2001, 40:3920-3930.
43. Pais J.E., Bowers K.E., Fierke C.A. Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase. J Am Chem Soc 2006, 128:15086-15087.
44. Wu Z., Demma M., Strickland C.L., Radisky E.S., Poulter C.D., Le H.V., Windsor W.T. Farnesyl protein transferase: identification of K164 alpha and Y300 beta as catalytic residues by mutagenesis and kinetic studies. Biochemistry 1999, 38:11239-11249.
45. Seabra M.C., Reiss Y., Casey P.J., Brown M.S., Goldstein J.L. Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit. Cell 1991, 65:429-434.
46. Kohl N.E., Diehl R.E., Schaber M.D., Rands E., Soderman D.D., He B., Moores S.L., Pompliano D.L., Ferro-Novick S., Powers S., et al. Structural homology among mammalian and saccharomyces cerevisiae isoprenyl-protein transferases. J Biol Chem 1991, 266:18884-18888.
47. Zhang F.L., Diehl R.E., Kohl N.E., Gibbs J.B., Giros B., Casey P.J., Omer C.A. Cdna cloning and expression of rat and human protein geranylgeranyltransferase type-I. J Biol Chem 1994, 269:3175-3180.
48. Chen W.J., Andres D.A., Goldstein J.L., Russell D.W., Brown M.S. cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransferase, the counterpart of yeast dpr1/ram1. Cell 1991, 66:327-334.
49. Li X., Liu L., Tupper J.C., Bannerman D.D., Winn R.K., Sebti S.M., Hamilton A.D., Harlan J.M. Inhibition of protein geranylgeranylation and rhoA/rhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem 2002, 277:15309-15316.
50. Moores S.L., Schaber M.D., Mosser S.D., Rands E., O'Hara M.B., Garsky V.M., Marshall M.S., Pompliano D.L., Gibbs J.B. Sequence dependence of protein isoprenylation. J Biol Chem 1991, 266:14603-14610.
51. Hartman H.L., Hicks K.A., Fierke C.A. Peptide specificity of protein prenyltransferases is determined mainly by reactivity rather than binding affinity. Biochemistry 2005, 44:15314-15324.
52. Hougland J.L., Lamphear C.L., Scott S.A., Gibbs R.A., Fierke C.A. Context-dependent substrate recognition by protein farnesyltransferase. Biochemistry 2009, 48:1691-1701.
53. James G.L., Goldstein J.L., Brown M.S. Polylysine and cvim sequences of k-rasb dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J Biol Chem 1995, 270:6221-6226.
54. Whyte D.B., Kirschmeier P., Hockenberry T.N., Nunez-Oliva I., James L., Catino J.J., Bishop W.R., Pai J.K. K- and N-ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem 1997, 272:14459-14464.
55. Rowell C.A., Kowalczyk J.J., Lewis M.D., Garcia A.M. Direct demonstration of geranylgeranylation and farnesylation of Ki-ras in vivo. J Biol Chem 1997, 272:14093-14097.
56. Armstrong S.A., Hannah V.C., Goldstein J.L., Brown M.S. CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to Rhob. J Biol Chem 1995, 270:7864-7868.
57. Lebowitz P.F., Casey P.J., Prendergast G.C., Thissen J.A. Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. J Biol Chem 1997, 272:15591-15594.
58. Baron R., Fourcade E., Lajoie-Mazenc I., Allal C., Couderc B., Barbaras R., Favre G., Faye J.C., Pradines A. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody. Proc Natl Acad Sci USA 2000, 97:11626-11631.
59. Hicks K.A., Hartman H.L., Fierke C.A. Upstream polybasic region in peptides enhances dual specificity for prenylation by both farnesyltransferase and geranylgeranyltransferase type I. Biochemistry 2005, 44:15325-15333.
60. Gibbs J.B., Oliff A. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Annu Rev Pharmacol Toxicol 1997, 37:143-166.
61. Zhang F.L., Moomaw J.F., Casey P.J. Properties and kinetic mechanism of recombinant mammalian protein geranylgeranyltransferase type I. J Biol Chem 1994, 269:23465-23470.
62. Zhang F.L., Casey P.J. Influence of metal ions on substrate binding and catalytic activity of mammalian protein geranylgeranyltransferase type-I. Biochem J 1996, 320(Pt 3):925-932.
63. DeGraw A.J., Hast M.A., Xu J., Mullen D., Beese L.S., Barany G., Distefano M.D. Caged protein prenyltransferase substrates: tools for understanding protein prenylation. Chem Biol Drug Des 2008, 72:171-181.
64. Nguyen U.T., Guo Z., Delon C., Wu Y., Deraeve C., Franzel B., Bon R.S., Blankenfeldt W., Goody R.S., Waldmann H., Wolters D., Alexandrov K. Analysis of the eukaryotic prenylome by isoprenoid affinity tagging. Nat Chem Biol 2009, 5:227-235.
65. Kho Y., Kim S.C., Jiang C., Barma D., Kwon S.W., Cheng J., Jaunbergs J., Weinbaum C., Tamanoi F., Falck J., Zhao Y. A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc Natl Acad Sci USA 2004, 101:12479-12484.